By Cristal Cody
Tupelo, Miss., March 21 – Medtronic plc priced $2 billion of senior notes (A3/A) in three fixed-rate tranches on Tuesday, according to a market source.
The offering included two tranches of fixed-rate notes placed by Medtronic Global Holdings SCA and guaranteed by Medtronic plc and Medtronic, Inc. The company dropped a planned offering of floating-rate notes.
Medtronic Global Holdings priced $1 billion of 1.7% two-year notes at a spread of Treasuries plus 47 basis points.
The company sold $850 million of 3.35% 10-year notes at 92 bps over Treasuries.
Also, subsidiary Medtronic, Inc. priced a $150 million add-on to the company’s 4.625% bonds due March 15, 2045 on Tuesday at a spread of Treasuries plus 117 bps.
The company originally sold $4 billion of the bonds on Dec. 1, 2014 at 99.732 to yield 4.642%, or 170 bps over Treasuries. The total outstanding now is $4.15 billion.
The reopened bonds are guaranteed by Medtronic plc and Medtronic Global Holdings SCA.
All three tranches priced on the tight side of guidance.
Citigroup Global Markets Inc., Goldman Sachs & Co. and Morgan Stanley & Co. LLC were the bookrunners.
The notes feature a make-whole call, with the 4.625% notes callable at Treasuries plus 30 bps until March 15, 2045, when they become callable at par, according to a 424B3 filing with the Securities and Exchange Commission.
Proceeds from the offering will be used for general corporate purposes.
Medtronic is a medical technology and services company based in Dublin. Subsidiary Medtronic Global Holdings is based in Luxembourg. Medtronic Inc. is based in Minneapolis.
| Issuer: | Medtronic plc
|
| Amount: | $2 billion
|
| Description: | Senior notes
|
| Bookrunners: | Citigroup Global Markets Inc., Goldman Sachs & Co. and Morgan Stanley & Co. LLC
|
| Trade date: | March 21
|
| Ratings: | Moody’s: A3
|
| S&P: A
|
| Distribution: | SEC registered
|
|
|
| Two-year notes
|
| Issuing entity: | Medtronic Global Holdings SCA
|
| Guarantors: | Medtronic plc and Medtronic, Inc.
|
| Amount: | $1 billion
|
| Maturity: | March 28, 2019
|
| Coupon: | 1.7%
|
| Spread: | Treasuries plus 47 bps
|
| Price guidance: | Treasuries plus 50 bps area, plus or minus 3 bps
|
| Call feature: | Make-whole call
|
|
|
| 10-year notes
|
| Issuing entity: | Medtronic Global Holdings SCA
|
| Guarantors: | Medtronic plc and Medtronic, Inc.
|
| Amount: | $850 million
|
| Maturity: | April 1, 2027
|
| Coupon: | 3.35%
|
| Spread: | Treasuries plus 92 bps
|
| Price guidance: | Treasuries plus 95 bps area, plus or minus 3 bps
|
| Call feature: | Make-whole call
|
|
|
| Add-on to notes due 2045
|
| Issuing entity: | Medtronic, Inc.
|
| Guarantors: | Medtronic plc and Medtronic Global Holdings SCA
|
| Amount: | $150 million reopening
|
| Maturity: | March 15, 2045
|
| Coupon: | 4.625%
|
| Spread: | Treasuries plus 117 bps
|
| Price guidance: | Treasuries plus 120 bps area, plus or minus 3 bps
|
| Call features: | Make-whole call at Treasuries plus 30 bps until March 15, 2045, thereafter at par
|
| Total outstanding: | $4.15 billion, including $4 billion priced on Dec. 1, 2014 to yield 170 bps over Treasuries
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
